First Department of Obstetrics and Gynaecology, Ludwig Maximilian University of Munich, Maistrasse 11, D-80337 Munich, Germany.
Oncol Rep. 2011 Oct;26(4):887-91. doi: 10.3892/or.2011.1379. Epub 2011 Jul 4.
Inhibins are dimeric glycoproteins composed of an α‑subunit and one of two possible β-subunits (βA or βB), with substantial roles in human reproduction and in endocrine-responsive tumours. Four normal cervical tissue samples together with 10 specimens of well-differentiated squamous cervical cancer and adenocarcinoma of the cervix were immunohistochemically analysed for the expression of the inhibin‑α subunit. Additionally, two cervical carcinoma cell lines (HeLa and CaSKi) were analysed with immunofluorescence and RT-PCR for the expression of the inhibin‑α subunit. We demonstrated for the first time an immunolabelling of the inhibin‑α subunit in normal and malignant cervical tissue, as well as cervical cancer cells. However, the immunoreactive reaction was albeit weak and mostly confined to mitotic cells in the analysed cervical tissues. Additionally, the expression pattern of this subunit was rather inconsistent. Therefore, the immunohistochemical evaluation of this subunit in cervical tissue cannot be used as a prognostic marker as suggested for endometrial cancer. However, since the expression of the inhibin‑α subunit is minimal in HeLa cells as assessed by immunofluorescence and RT-PCR, the CaSKi cell line might be a better model for further functional experiments regarding cervical pathogenesis.
抑制素是由一个 α-亚基和两个可能的 β-亚基(βA 或 βB)组成的二聚糖蛋白,在人类生殖和内分泌反应性肿瘤中具有重要作用。对 4 例正常宫颈组织标本和 10 例分化良好的宫颈鳞状细胞癌和宫颈腺癌标本进行了抑制素-α 亚基的免疫组织化学分析。此外,还通过免疫荧光和 RT-PCR 分析了两种宫颈癌细胞系(HeLa 和 CaSKi)中抑制素-α 亚基的表达。我们首次在正常和恶性宫颈组织以及宫颈癌细胞中证明了抑制素-α 亚基的免疫标记。然而,免疫反应虽然较弱,但主要局限于分析的宫颈组织中的有丝分裂细胞。此外,该亚基的表达模式相当不一致。因此,如子宫内膜癌所建议的那样,在宫颈组织中对该亚基的免疫组织化学评估不能用作预后标志物。然而,由于免疫荧光和 RT-PCR 评估,HeLa 细胞中抑制素-α 亚基的表达极小,因此 CaSKi 细胞系可能是进一步研究宫颈发病机制的功能实验的更好模型。